Tags Archives: SARS‐CoV‐2

thumbnail
0 comment

Effect of Cardiopulmonary Bypass on SARS‐CoV‐2 Vaccination Antibody Levels

Abstract Background Adults undergoing heart surgery are particularly vulnerable to respiratory complications, including COVID‐19. Immunization can significantly reduce this risk; however, the effect of cardiopulmonary bypass (CPB) on immunization status..

Read More
thumbnail
0 comment

Cardiac surgery with cardiopulmonary bypass markedly lowers SARS-COV-2 antibody titer

Abstract Background This study aims to investigate the effect of cardiopulmonary bypass on antibody titers in patients vaccinated against the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) undergoing cardiac surgery with..

Read More
thumbnail
0 comment

Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis

Abstract Background Extracorporeal membrane oxygenation (ECMO) has been used extensively for coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). Reports early in the pandemic suggested that mortality in patients..

Read More
thumbnail
0 comment

Evolving outcomes of extracorporeal membrane oxygenation support for severe COVID‑19 ARDS in Sorbonne hospitals, Paris

Abstract Background Extracorporeal membrane oxygenation (ECMO) was frequently used to treat patients with severe coronavirus disease‑2019 (COVID‑19)‑associated acute respiratory distress (ARDS) during the initial outbreak. Care of COVID‑19 patients evolved..

Read More
thumbnail
0 comment

Taskforce report on the diagnosis and clinical management of COVID‑19 associated pulmonary aspergillosis

Abstract Purpose: Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus disease 2019 (COVID‑19) admitted to the intensive care unit (ICU). Diagnosis and management of COVID‑19 associated..

Read More
thumbnail
0 comment

Implementation of new ECMO centers during the COVID‑19 pandemic: experience and results from the Middle East and India

Abstract Purpose: Extracorporeal membrane oxygenation (ECMO) use for severe coronavirus disease 2019 (COVID‑19) patients has increased during the course of the pandemic. As uncertainty existed regarding patient’s outcomes, early guidelines..

Read More
thumbnail
0 comment

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Abstract Both antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID‐19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a..

Read More
thumbnail
0 comment

Extracorporeal life support in COVID‐19‐related acute respiratory distress syndrome: A EuroELSO international survey

Abstract Extracorporeal life support (ECLS) is a means to support patients with acute respiratory failure. Initially, recommendations to treat severe cases of pandemic coronavirus disease 2019 (COVID‐19) with ECLS have..

Read More